SCHEMBL4774809

SCHEMBL4774809

COCCOCN(c1onc(C)c1C)S(=O)(=O)c1ccccc1-c1ccc(C=O)cc1C

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
EDNRA P25101 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4770625 0.92 ALOX5AP (0.35) MAPTTP53EDNRA
SCHEMBL5530252 0.91 TP53 (0.32) MAPTTP53EDNRA
SCHEMBL4769127 0.91 EDNRA (0.36) MAPTTP53EDNRAALDH1A1
SCHEMBL4771977 0.89 EDNRA (0.35) MAPTTP53EDNRA
SCHEMBL4767340 0.89 EDNRA (0.39) EDNRA
SCHEMBL4774144 0.89 TP53 (0.39) MAPTTP53EDNRA
SCHEMBL4774430 0.87 EDNRA (0.34) EDNRA
SCHEMBL4770890 0.87 TP53 (0.31) MAPTTP53
SCHEMBL4774008 0.84 EDNRB (0.36) EDNRA
SCHEMBL4764327 0.84 EDNRA (0.35) MAPTEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2002837-A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-17 EP disclosed
EP-1094816-B1 BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2008-12-10 EP disclosed
EP-1741713-A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists Bristol-Myers Squibb Company (US) 2007-01-10 EP disclosed
EP-1237888-B1 BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2006-09-13 EP disclosed
US-6835741-B2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists BRISTOL-MYERS SQUIBB COMPANY 2004-12-28 US disclosed
US-6638937-B2 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer BRISTOL-MYERS SQUIBB CO. 2003-10-28 US disclosed